Search
for
Sort by
Research 331–360 of 1000+
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- HuR ablation destabilizes Foxp3 mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype
- MicroRNA-mediated regulation of hair follicle regeneration: mechanisms, delivery strategies, and translational perspectives
- Role of skin microbiome and exosomes in Hair regeneration and disorders in diseases like Alopecia, Acne: A comprehensive review
- CD27 and IL-35 as diagnostic biomarkers in alopecia areata: First evidence of association with pathogenic scalp bacterial infections
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Mendelian Randomization Identifies CD25+ CD4+ Tregs and Plasma Proteins in Androgenetic Alopecia Pathogenesis
- Mechanistic study of Erianin in alopecia areata
- Immunopathogenesis of Primary Cicatricial Alopecia
- 1310 Anti-aging effects of retinoid hydroxypinacolone retinoate on skin models
- Evaluation of Animal Models Suitable for Hair Research and Regeneration
- Pathophysiology of the burn scar
- Current and future pharmacotherapy for alopecia areata
- Selected topics in pediatric hair loss
- 061 Selective inhibition of tyrosine kinase 2 prevents and restores interleukin-12-induced hair follicle immune privilege collapse: a novel approach to alopecia areata therapy?
- LB1777 A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- Immune therapies for alopecia areata: evidence and new perspectives
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- 90 Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- ISIDLB1777 - A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- Unveiling the immune and vitamin profiles of blood: the potential biomarkers for alopecia areata
- Tracing immune cells around biomaterials with spatial anchors during large-scale wound regeneration
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Inflammatory loops in the epithelial–immune microenvironment of the skin and skin appendages in chronic inflammatory diseases
- Inheritance-Specific Dysregulation of Th1- and Th17-Associated Cytokines in Alopecia Areata
- The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review
- Author response: Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo